๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose

โœ Scribed by P. J. McNamara; K. Stoeckel; W. H. Ziegler


Publisher
Springer
Year
1982
Tongue
English
Weight
490 KB
Volume
22
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics of dolasetron following
โœ Ajit Shah; Robert Lanman; Vijay Bhargava; Scott Weir; William Hahne ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 561 KB

Dolasetron, AnzemetTM, a 5-hydroxytryptamine receptor antagonist, is under investigation as an antiemetic agent. The keto-reduced metabolite of dolasetron has been identified in human plasma and is probably responsible for the majority of the antiemetic activity. This study evaluated the pharmacokin

Pharmacokinetics of piperacillin and gen
โœ Vijay K. Batra; John A. Morrison; Thomas R. Hoffman ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 573 KB

for assistance in the statistical evaluation of some of the results obtained from experimentation with mitochondria and also to the National Cancer Institute, Bethesda, Md., which undertook the antineoplastic evaluation of some of the compounds reported in this investigation.